US Stock MarketDetailed Quotes

EVAX Evaxion Biotech

Watchlist
  • 1.570
  • -0.040-2.48%
Close Nov 27 16:00 ET
  • 1.570
  • 0.0000.00%
Post 20:02 ET
9.21MMarket Cap-560P/E (TTM)

Evaxion Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
3.02M
154K
51K
73K
73K
0
0
0
0
0
Operating revenue
--3.02M
--154K
--51K
--73K
--73K
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-17.60%4.75M
-16.59%4.74M
-29.46%4.45M
-11.85%22.27M
-32.00%4.44M
-5.28%5.76M
-9.30%5.68M
-1.48%6.3M
-2.21%25.26M
-15.49%6.53M
Selling and administrative expenses
-27.22%2.13M
-27.65%1.98M
-34.30%1.61M
24.99%10.08M
-19.24%1.86M
45.51%2.93M
27.67%2.74M
53.73%2.45M
30.49%8.06M
54.28%2.31M
-General and administrative expense
-27.22%2.13M
-27.65%1.98M
-34.30%1.61M
24.99%10.08M
-19.24%1.86M
45.51%2.93M
27.67%2.74M
53.73%2.45M
30.49%8.06M
54.28%2.31M
Research and development costs
-7.63%2.61M
-6.27%2.75M
-26.38%2.84M
-30.14%11.92M
-43.58%2.3M
-30.43%2.83M
-28.60%2.94M
-19.82%3.85M
-12.90%17.06M
-33.82%4.07M
Depreciation amortization depletion
----
----
----
90.97%275K
----
----
----
----
102.82%144K
----
-Depreciation and amortization
----
----
----
90.97%275K
----
----
----
----
102.82%144K
----
Operating profit
69.96%-1.73M
19.31%-4.58M
30.27%-4.4M
12.14%-22.2M
33.12%-4.36M
5.28%-5.76M
9.30%-5.68M
1.48%-6.3M
2.21%-25.26M
15.49%-6.53M
Net non-operating interest income expense
-172.73%-300K
-5.75%-184K
13,202.44%5.37M
5.35%-743K
86.26%-361K
-165.48%-110K
-113.24%-174K
-111.36%-41K
-393.71%-785K
-331.53%-2.63M
Non-operating interest income
16.67%84K
-12.77%41K
1,871.23%5.62M
1,084.62%154K
90.90%-250K
-89.76%72K
-96.95%47K
-45.09%285K
--13K
-112.53%-2.75M
Non-operating interest expense
110.99%384K
1.81%225K
-24.54%246K
12.41%897K
192.50%111K
-65.98%182K
-1.78%221K
106.33%326K
401.89%798K
82.46%-120K
Other net income (expense)
-2,763.16%-1.63M
-98.81%25K
-57K
64.30%2.11M
Gain on sale of security
----
-2,763.16%-1.63M
----
-98.81%25K
----
----
---57K
----
64.30%2.11M
----
Income before tax
65.41%-2.03M
-8.28%-6.4M
115.17%976K
4.29%-22.92M
33.29%-4.7M
0.73%-5.87M
-19.47%-5.91M
-6.58%-6.44M
3.11%-23.94M
0.03%-7.05M
Income tax
50.52%-96K
11.56%-199K
-12.37%-218K
-2.33%-790K
-2.31%-177K
-10.86%-194K
-27.12%-225K
21.46%-194K
-333.71%-772K
-113.08%-173K
Net income
65.92%-1.94M
-9.06%-6.2M
119.13%1.19M
4.51%-22.13M
34.18%-4.52M
1.08%-5.68M
-19.19%-5.68M
-7.77%-6.24M
5.56%-23.17M
17.90%-6.87M
Net income continuous Operations
65.92%-1.94M
-9.06%-6.2M
119.13%1.19M
4.51%-22.13M
34.18%-4.52M
1.08%-5.68M
-19.19%-5.68M
-7.77%-6.24M
5.56%-23.17M
17.90%-6.87M
Minority interest income
Net income attributable to the parent company
65.92%-1.94M
-9.06%-6.2M
119.13%1.19M
4.51%-22.13M
34.18%-4.52M
1.08%-5.68M
-19.19%-5.68M
-7.77%-6.24M
5.56%-23.17M
17.90%-6.87M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
65.92%-1.94M
-9.06%-6.2M
119.13%1.19M
4.51%-22.13M
34.18%-4.52M
1.08%-5.68M
-19.19%-5.68M
-7.77%-6.24M
5.56%-23.17M
17.90%-6.87M
Basic earnings per share
80.95%-0.4
42.86%-1.2
112.50%0.3
17.35%-8.1
48.28%-1.5
12.50%-2.1
-5.00%-2.1
4.00%-2.4
22.22%-9.8
25.64%-2.9
Diluted earnings per share
80.95%-0.4
42.86%-1.2
112.50%0.3
17.35%-8.1
48.28%-1.5
12.50%-2.1
-5.00%-2.1
4.00%-2.4
22.22%-9.8
25.64%-2.9
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 3.02M154K51K73K73K00000
Operating revenue --3.02M--154K--51K--73K--73K--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -17.60%4.75M-16.59%4.74M-29.46%4.45M-11.85%22.27M-32.00%4.44M-5.28%5.76M-9.30%5.68M-1.48%6.3M-2.21%25.26M-15.49%6.53M
Selling and administrative expenses -27.22%2.13M-27.65%1.98M-34.30%1.61M24.99%10.08M-19.24%1.86M45.51%2.93M27.67%2.74M53.73%2.45M30.49%8.06M54.28%2.31M
-General and administrative expense -27.22%2.13M-27.65%1.98M-34.30%1.61M24.99%10.08M-19.24%1.86M45.51%2.93M27.67%2.74M53.73%2.45M30.49%8.06M54.28%2.31M
Research and development costs -7.63%2.61M-6.27%2.75M-26.38%2.84M-30.14%11.92M-43.58%2.3M-30.43%2.83M-28.60%2.94M-19.82%3.85M-12.90%17.06M-33.82%4.07M
Depreciation amortization depletion ------------90.97%275K----------------102.82%144K----
-Depreciation and amortization ------------90.97%275K----------------102.82%144K----
Operating profit 69.96%-1.73M19.31%-4.58M30.27%-4.4M12.14%-22.2M33.12%-4.36M5.28%-5.76M9.30%-5.68M1.48%-6.3M2.21%-25.26M15.49%-6.53M
Net non-operating interest income expense -172.73%-300K-5.75%-184K13,202.44%5.37M5.35%-743K86.26%-361K-165.48%-110K-113.24%-174K-111.36%-41K-393.71%-785K-331.53%-2.63M
Non-operating interest income 16.67%84K-12.77%41K1,871.23%5.62M1,084.62%154K90.90%-250K-89.76%72K-96.95%47K-45.09%285K--13K-112.53%-2.75M
Non-operating interest expense 110.99%384K1.81%225K-24.54%246K12.41%897K192.50%111K-65.98%182K-1.78%221K106.33%326K401.89%798K82.46%-120K
Other net income (expense) -2,763.16%-1.63M-98.81%25K-57K64.30%2.11M
Gain on sale of security -----2,763.16%-1.63M-----98.81%25K-----------57K----64.30%2.11M----
Income before tax 65.41%-2.03M-8.28%-6.4M115.17%976K4.29%-22.92M33.29%-4.7M0.73%-5.87M-19.47%-5.91M-6.58%-6.44M3.11%-23.94M0.03%-7.05M
Income tax 50.52%-96K11.56%-199K-12.37%-218K-2.33%-790K-2.31%-177K-10.86%-194K-27.12%-225K21.46%-194K-333.71%-772K-113.08%-173K
Net income 65.92%-1.94M-9.06%-6.2M119.13%1.19M4.51%-22.13M34.18%-4.52M1.08%-5.68M-19.19%-5.68M-7.77%-6.24M5.56%-23.17M17.90%-6.87M
Net income continuous Operations 65.92%-1.94M-9.06%-6.2M119.13%1.19M4.51%-22.13M34.18%-4.52M1.08%-5.68M-19.19%-5.68M-7.77%-6.24M5.56%-23.17M17.90%-6.87M
Minority interest income
Net income attributable to the parent company 65.92%-1.94M-9.06%-6.2M119.13%1.19M4.51%-22.13M34.18%-4.52M1.08%-5.68M-19.19%-5.68M-7.77%-6.24M5.56%-23.17M17.90%-6.87M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 65.92%-1.94M-9.06%-6.2M119.13%1.19M4.51%-22.13M34.18%-4.52M1.08%-5.68M-19.19%-5.68M-7.77%-6.24M5.56%-23.17M17.90%-6.87M
Basic earnings per share 80.95%-0.442.86%-1.2112.50%0.317.35%-8.148.28%-1.512.50%-2.1-5.00%-2.14.00%-2.422.22%-9.825.64%-2.9
Diluted earnings per share 80.95%-0.442.86%-1.2112.50%0.317.35%-8.148.28%-1.512.50%-2.1-5.00%-2.14.00%-2.422.22%-9.825.64%-2.9
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data